1,688 results on '"Morishima, Y"'
Search Results
2. Blood Eosinophil Phenotype During Treatment With Mepolizumab in Patients With Severe Eosinophilic Asthma
3. Protective Role of Nrf2 in HDM-induced Neutrophilic Airway Inflammation
4. The Role for Mitochondria in the Development of Pulmonary Emphysema
5. Auditory closed-loop modulation of slow wave sleep to treat major depressive disorder
6. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
7. Selective slow-wave sleep suppression through auditory closed-loop stimulation
8. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation
9. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease
10. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation
11. Chaperoning of Glucocorticoid Receptors
12. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes
13. Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation
14. ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
15. Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT
16. Topic: Incisional Hernia — “Easy case” as daily case: open vs lap, where the mesh, which fixation…in center midline cases
17. Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan
18. Immunohistochemical detection of meconium in the fetal membrane, placenta and umbilical cord
19. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT
20. A Double-blind Controlled Study of G-CSF Started Two Days Before Induction Chemotherapy in Refractory Acute Myeloid Leukemia
21. Novel Unimolecular Micelles of Hydrophobically Modified Polyelectrolytes: Synthesis, Characterization, and Functions
22. Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809
23. PBSC collection from family donors in Japan: a prospective survey
24. Risk factors and organ involvement of chronic GVHD in Japan
25. Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis
26. Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
27. Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
28. Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events
29. Intensive Induction Therapy with Behenoyl, Cytosine Arabinoside, Daunorubicin, and 6-Mercaptopurine Followed by Intensive Consolidation with Mitoxantrone, Etoposide, Vincristine, and Intermediate-Dose Continuous Cytarabine (M-85 Protocol) for Adult Acute Myelogenous Leukemia
30. Thrombotic safety of a four-factor prothrombin complex concentrate (Beriplex P/N) for edoxaban reversal in a rabbit model: OR316
31. Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation
32. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
33. The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis
34. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry
35. Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR
36. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers
37. Search for Host Factors That Predict the Therapeutic Effect of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF)
38. Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas
39. DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles
40. A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT
41. Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan marrow donor program
42. A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies
43. Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia
44. Long-term changes in sediment type and cavernicolous bivalve assemblages in Daidokutsu submarine cave, Okinawa Islands: evidence from a new core extending over the past 7,000 years
45. VIRAL INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM UNRELATED DONORS: ON BEHALF OF COMPLICATIONS WORKING GROUP OF THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT): PH-O026
46. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
47. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
48. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206
49. High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas
50. Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.